Heart failure after Caesarean section for twin delivery.
Crivellari
M
M
Bove
T
T
Landoni
G
G
Zangrillo
A
A
D000328:Adult; D000773:Anesthesia, Obstetrical / Q000379:methods; D000775:Anesthesia, Spinal / Q000379:methods; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002407:Catheterization, Swan-Ganz / Q000379:methods; D002585:Cesarean Section / Q000009:adverse effects* / Q000379:methods*; D003937:Diagnosis, Differential; D004077:Digoxin / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004280:Dobutamine / Q000627:therapeutic use; D004562:Electrocardiography / Q000379:methods; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006333:Heart Failure / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D007442:Intubation, Intratracheal / Q000379:methods; D009599:Nitroprusside / Q000627:therapeutic use; D011654:Pulmonary Edema / Q000150:complications* / Q000188:drug therapy; D014427:Twins; D014665:Vasodilator Agents / Q000627:therapeutic use
D002316:Cardiotonic Agents; D004232:Diuretics; D014665:Vasodilator Agents; D009599:Nitroprusside; D006830:Hydralazine; D004280:Dobutamine; D004077:Digoxin; D005665:Furosemide